ENTX Earnings Date: Nov 13, 2026 (Estimated) — Entera Bio Ltd.
NASDAQ
Updated
When is ENTX's next earnings date?
Entera Bio Ltd. (ENTX) is expected to report Q3 2026 earnings on Friday, November 13, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.07.
How did ENTX do in its last earnings report?
In its most recent report on Aug 7, 2026 (Q2 2026), Entera Bio Ltd. posted EPS of -$0.14 versus the -$0.08 estimate, a miss of 75.0%. Revenue was $0. The stock's 1-day post-earnings move was +5.9%.
How much does ENTX stock move after earnings?
ENTX beat EPS estimates in 4 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 4.8% (up or down) in the day after earnings.
About Entera Bio Ltd.
Entera Bio Ltd. is a biopharmaceutical firm in the clinical development phase, dedicated to creating and marketing oral medications composed of large molecules, addressing medical conditions that currently lack adequate treatments. Its primary experimental drugs are EB612, currently undergoing Phase II clinical assessment for hypoparathyroidism, and EB613, which has concluded Phase II studies for osteoporosis and is now in Phase I trials for treating non-healing bone fractures. Furthermore, the company holds a collaborative research and licensing pact with Amgen Inc. aimed at identifying and advancing potential therapeutic compounds for inflammatory conditions and other grave ailments. Established in 2009, Entera Bio Ltd. operates from its headquarters in Jerusalem, Israel.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-07 | Q2 2026 | -0.08 | -0.14 | -75.00% | $0 | ❌ Miss | +5.92% | +0.70% | +4.88% |
| 2026-05-08 | Q1 2026 | -0.08 | -0.07 | +12.50% | $0 | ✅ Beat | -10.00% | -3.08% | -6.15% |
| 2026-03-27 | Q4 2025 | -0.09 | -0.06 | +33.33% | $0 | ✅ Beat | -11.50% | +5.31% | +0.00% |
| 2025-11-14 | Q3 2025 | -0.09 | -0.07 | +22.22% | $0 | ✅ Beat | -1.11% | -6.64% | -22.88% |
| 2025-08-08 | Q2 2025 | 1.21 | -0.06 | -104.96% | $0 | ❌ Miss | +3.30% | +9.89% | +2.20% |
| 2025-03-28 | Q4 2024 | -0.08 | -0.06 | +25.00% | $82,000 | ✅ Beat | -2.86% | -8.57% | +27.43% |
| 2024-11-08 | Q3 2024 | -0.05 | -0.08 | -60.00% | $42,000 | ❌ Miss | -1.16% | +0.58% | +33.14% |
| 2024-08-09 | Q2 2024 | -0.06 | -0.06 | +0.00% | $57,000 | ➖ Inline | -2.50% | +1.88% | +16.25% |
Showing last 8 quarters.